{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:31:34Z","timestamp":1795059094946,"version":"4.10.2"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective &amp; Background:<\/jats:title>\n                    <jats:p>Combined pancreatic and vascular resections are increasingly performed for pancreatic ductal adenocarcinoma (PDAC). We evaluated the outcomes after pancreatectomy with nonvascular resection (NVR), venous resection (VR), and arterial resection (AR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective review (2011\u20132023) of 715 patients with PDAC treated with curative-intent surgery. Associations among clinicopathological data, perioperative therapy, time to recurrence (TTR), and overall survival (OS) were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Initial staging revealed 533 resectable, 98 borderline, and 84 locally advanced PDAC cases. Pancreaticoduodenectomy was the most common procedure (n = 467). NVR was performed in 351 (58.2%) patients, VR in 181 (30.0%), and AR in 70 (11.8%). The median TTR and OS did not significantly differ according to the initial staging or type of pancreas resection. Median TTR and OS were significantly shorter for VR (14.5 and 22.7 months) compared with NVR (18.6 and 30.5 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and AR (20.6 and 30.9 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017). Chemotherapy or chemoradiation significantly prolonged TTR (20.1 vs 10.2 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 and 25.3 vs 16.4 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and OS (31.5 vs 17.2 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 and 35.5 vs 27.5 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.030). AR was associated with higher 90-day mortality rates. In the multivariable analysis, vascular resection was not associated with OS. Perioperative therapy, pathologic N0 status, and absence of perineural invasion were the key predictors of longer TTR and OS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Pancreatectomy with AR was not associated with worse oncological outcomes when controlling for perioperative therapy. However, AR was associated with higher 90-day mortality rates. Patient selection is crucial when performing AR in patients with PDAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000006567","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T05:00:36Z","timestamp":1729054836000},"page":"1009-1019","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Vascular Resection for Pancreas Cancer"],"prefix":"10.1097","volume":"283","author":[{"given":"David","family":"Henault","sequence":"first","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holden","family":"Kunde","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Zatzman","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bevacqua","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.A.","family":"Arshinoff","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Cleary","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Elimova","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Knox","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruz","family":"Mesci","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol-Anne E.","family":"Moulton","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W.","family":"Reichman","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaya","family":"Shwaartz","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Tsang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"McGilvray","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Gallinger","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgical Oncology Service, University Health Network, Toronto, Canada"},{"name":"Hepato-Pancreato-Biliary Oncology Research Center at University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"R1-20260512","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"E574","DOI":"10.1503\/cmaj.190211","article-title":"Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis","volume":"191","author":"Mavros","year":"2019","journal-title":"CMAJ"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hpb.2017.02.437","article-title":"Superior mesenteric artery (SMA) resection during pancreatectomy for malignant disease of the pancreas: a systematic review","volume":"19","author":"Jegatheeswaran","year":"2017","journal-title":"HPB (Oxford)"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jamcollsurg.2018.05.001","article-title":"Indications and perioperative outcomes for pancreatectomy with arterial resection","volume":"227","author":"Tee","year":"2018","journal-title":"J Am Coll Surg"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/SLA.0b013e31823ac299","article-title":"Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis","volume":"254","author":"Mollberg","year":"2011","journal-title":"Ann Surg"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMsa012337","article-title":"Hospital volume and surgical mortality in the United States","volume":"346","author":"Birkmeyer","year":"2002","journal-title":"N Engl J Med"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.hpb.2020.04.005","article-title":"Arterial resections in pancreatic cancer - systematic review and meta-analysis","volume":"22","author":"Malczak","year":"2020","journal-title":"HPB (Oxford)"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.surg.2015.09.018","article-title":"Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy","volume":"159","author":"Christians","year":"2016","journal-title":"Surgery"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00423-018-1724-8","article-title":"Neoadjuvant and adjuvant chemotherapy in pancreatic cancer","volume":"403","author":"Klaiber","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/bjs.10870","article-title":"Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer","volume":"105","author":"Versteijne","year":"2018","journal-title":"Br J Surg"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/bjs.10603","article-title":"Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy","volume":"104","author":"Kleive","year":"2017","journal-title":"Br J Surg"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.hpb.2018.10.004","article-title":"Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas","volume":"21","author":"Loveday","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/SLA.0000000000003284","article-title":"Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline\/locally advanced pancreatic cancer","volume":"273","author":"Truty","year":"2021","journal-title":"Ann Surg"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"R19-20260512","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","article-title":"Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)","volume":"155","author":"Bockhorn","year":"2014","journal-title":"Surgery"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/bjs.9222","article-title":"Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma","volume":"100","author":"Kim","year":"2013","journal-title":"Br J Surg"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.annonc.2024.05.469","article-title":"326P NeoPancONE: Feasibility of completing a neoadjuvant multicentre phase II study in resectable pancreatic ductal adenocarcinoma (r-PDAC), treated with modified FOLFIRINOX (mFFX)","volume":"35","author":"McLaughlin","year":"2024","journal-title":"Ann Oncol"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/curroncol31050194","article-title":"Impact of an inter-professional clinic on pancreatic cancer outcomes: a retrospective cohort study","volume":"31","author":"Moffat","year":"2024","journal-title":"Curr Oncol"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1245\/s10434-018-07101-0","article-title":"Outcomes and risk score for distal pancreatectomy with celiac axis resection (DP-CAR): an international multicenter analysis","volume":"26","author":"Klompmaker","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/bjs.10148","article-title":"Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer","volume":"103","author":"Klompmaker","year":"2016","journal-title":"Br J Surg"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1097\/JS9.0000000000000742","article-title":"Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis","volume":"109","author":"Xue","year":"2023","journal-title":"Int J Surg"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/SLA.0000000000004054","article-title":"Arterial resection in pancreatic cancer surgery: effective after a learning curve","volume":"275","author":"Loos","year":"2022","journal-title":"Ann Surg"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:28:05Z","timestamp":1778596085000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006567"}},"subtitle":["Ten Years Experience From a Single High-volume Center"],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000006567","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}